What we do
With deep expertise across the product lifecycle, we help clients navigate the complexities, turning challenges into opportunities. Our experience ensures strategic guidance and actionable insights that drive success from development through launch and beyond.
Early development
Early Launch Preparation
Filing & launch
Post Launch & Lifecycle Optimisation
Focus areas
While we support a broad range of therapy areas, our experience clusters into four domains that account for the vast majority of our work. From early clinical development through loss of exclusivity, we help clients secure—and sustain—market access with evidence‑based, payer‑relevant strategies.
Pharmaceuticals
Early clinical development through Loss of Exclusivity
Around two‑thirds of our portfolio is pharmaceutical, with pronounced depth in ophthalmology, immunology, neurology, haematology and oncology. Roughly 30% of these engagements involve rare‑disease assets, giving us hands‑on expertise with orphan‑drug incentives, early‑access schemes and bespoke evidence plans.
Immunology
Coming soon
Neurology
Coming soon
Ophthalmology
Coming soon
Oncology
Coming soon
Rare Disease
Coming soon
MedTech & Diagnostics
Devices, Companion Diagnostics & Digital Health
About one in five of our engagements centres on MedTech and diagnostics, spanning devices, digital biomarkers and companion diagnostics across EU and global markets.
Medical Nutrition
Economic Impact & Real‑World Outcomes
Medical nutrition represents roughly one in six projects. We demonstrate how targeted nutritional interventions reduce costs, improve pathways and enhance patient outcomes—securing reimbursement for innovative nutrition therapies.
Environmental Sustainability (ESG)
Embedding Environmental Sustainability Criteria into Access Strategies
As procurement frameworks increasingly reward sustainability, our pilot projects have mapped payer ESG criteria to product attributes, benchmarked competitors and built clear ESG value narratives—positioning clients ahead of evolving requirements.
....and many other therapy areas
If you don’t see your indication listed—or if your project spans multiple domains—let’s talk. Our boutique approach means every engagement is tailored to your unique needs.
Internal resources
